FHS PI and Director, Vasan Ramachandran, M.D., named AHA’s 2021 Distinguished Scientist in General Preventive Medicine
Framingham Heart Study Principal Investigator and Director, Vasan S. Ramachandran, M.D., named the American Heart Association’s 2021 Distinguished Scientist in General Preventive Medicine Per the American Heart Association (AHA) — Dr. Ramachandran was selected for this honor because of the impact of his work on clinical practice in cardiovascular health, significant contributions to the […]
Dr. Vasan Ramachandran, FHS Principal Investigator and Director, receives Lucian Prize
Dr. Vasan Ramachandran, FHS Principal Investigator and Director, receives prestigious Lucian Prize for contributions to cardiovascular science c/o — BOSTON UNIVERSITY SCHOOL OF MEDICINE (Boston) — Vasan Ramachandran, MD, FACC, the Jay and Louise Coffman Professor in Vascular Medicine at Boston University School of Medicine (BUSM), has been selected as the 2021 recipient of the […]
Design, deployment, and usability of a mobile system for cardiovascular health monitoring within the electronic Framingham Heart Study
Design, deployment, and usability of a mobile system for cardiovascular health monitoring within the electronic Framingham Heart Study (eFHS) Read about eFHS: an FHS ancillary study in which FHS participants are using a smartphone app and other digital tools to track their health and complete survey assessments! Usability and adherence results are from researchers […]
Recent Findings: Autonomic Imbalance and Risk of Dementia and Stroke
Autonomic Imbalance and Risk of Dementia and Stroke: The Framingham Heart Study by Galit Weinstein, Kendra Davis-Plourde, Alexa S. Beiser, Sudha Seshadri Published 20 Apr 2021 Abstract Background and Purpose: The autonomic nervous system has been implicated in stroke and dementia pathophysiology. High resting heart rate and low heart rate variability indicate the effect of […]
Recent Findings: ASCVD risk factors also risk for Cancer: Lau et al., 2021
An FHS & PREVEND collaboration finds that atherosclerotic (ASCVD) risk factors, except hypertension, are risk factors for cancer Abstract Background The extent to which co-occurrence of cardiovascular disease (CVD) and cancer is due to shared risk factors or other mechanisms is unknown. Objectives This study investigated the association of standard CVD risk factors, CVD biomarkers, […]
Revisiting: NHLBI Orloff Award 2019: Andrew Johnson
NHLBI Orloff Award 2019: Andrew Johnson, Ph.D. Dr. Andrew Johnson explains how his team set out on a mission to determine which genes drive platelet count and reactivity, with the ultimate goal of preventing cardiovascular disease. This video is by the National Heart, Lung, and Blood Institute (NHLBI), part of the National Institutes of Health […]
FHS Paper Selected as Hypertension High Impact Paper for Spring 2021
FHS Paper Selected as Hypertension High Impact Paper for Spring 2021 The recently published article, “Intrinsic Frequencies of Carotid Pressure Waveforms Predict Heart Failure Events” from FHS researchers was selected as a High Impact Paper for Spring 2021 in the category of population science. High Impact papers are selected every quarter by the editors of […]
Exercise, healthy diet in midlife may prevent serious health conditions in senior years
Exercise, healthy diet in midlife may prevent serious health conditions in senior years From Journal of the American Heart Association Report Research Highlights: Regular exercise and a healthy diet for middle-aged adults may be key to achieving optimal cardiometabolic health later in life. Cardiometabolic health risk factors include the metabolic syndrome, a cluster of health […]
A 12-minute workout can activate hundreds of heart-healthy molecules (from NHBLI and FHS in the Press)
A 12-minute workout can activate hundreds of heart-healthy molecules Scientists know exercise is good for the heart, but a study in the scientific journal Circulation explains molecular processes that promote metabolic health and reduce the risk for heart disease. For example, metabolites associated with diabetes and cardiovascular disease fell 29% during exercise. Metabolites associated with […]
Tuhina Neogi, MD, PhD to be named as the Alan S. Cohen, MD Professor of Rheumatology
Tuhina Neogi, MD, PhD to be as the Alan S. Cohen, MD Professor of Rheumatology The Framingham Heart Study wishes to congratulate FHS investigator Tuhina Neogi, MD, PhD on her upcoming installation as the Alan S. Cohen, MD Professor of Rheumatology. Dr. Neogi is a rheumatologist and epidemiologist whose research has focused primarily on risk factors […]